IE
NEO icon

Israel Englander’s NeoGenomics NEO Stock Holding History

Israel Englander’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,000
Closed -$198K – 6225
2024
Q4 		$198K Sell
12,000
-18,000
-60% -$280K ﹤0.01% 5311
2024
Q3 		$443K Buy
+30,000
New +$469K ﹤0.01% 4923
2024
Q1 		– Sell
-50,000
Closed -$809K – 6492
2023
Q4 		$809K Buy
+50,000
New +$818K ﹤0.01% 4316
2022
Q2 		– Sell
-25,000
Closed -$304K – 7312
2022
Q1 		$304K Buy
+25,000
New +$526K ﹤0.01% 5527

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Israel Englander's NEO Position: Q2 2026 in Review

Israel Englander increased its NeoGenomics (NEO) stake by 39% in Q2 2026, buying an estimated $8.27M and bringing the position to 3,079,542 shares worth $44.9M. The position accounts for 0.02% of the portfolio, ranked #965.

Israel Englander first reported a position in NEO in Q4 2013 and has held it in 40 quarters since. The position peaked at $63.8M in Q1 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Israel Englander held 3,079,542 shares of NeoGenomics worth $44.9M as of Q2 2026.
  • Israel Englander bought 856,785 NeoGenomics shares in Q2 2026, an estimated $8.27M.
  • NeoGenomics made up 0.02% of Israel Englander's portfolio in Q2 2026, its #965 holding.
  • Israel Englander first reported a position in NeoGenomics in Q4 2013 and has held it in 40 quarters since.
  • Israel Englander's NeoGenomics position peaked at $63.8M in Q1 2025.
  • 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.